Search Results - "Jang, Hyunbum"

Refine Results
  1. 1

    The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B by Lu, Shaoyong, Jang, Hyunbum, Nussinov, Ruth, Zhang, Jian

    Published in Scientific reports (23-02-2016)
    “…Ras mediates cell proliferation, survival and differentiation. Mutations in K-Ras4B are predominant at residues G12, G13 and Q61. Even though all impair…”
    Get full text
    Journal Article
  2. 2

    Oncogenic Ras Isoforms Signaling Specificity at the Membrane by Nussinov, Ruth, Tsai, Chung-Jung, Jang, Hyunbum

    Published in Cancer research (Chicago, Ill.) (01-02-2018)
    “…How do Ras isoforms attain oncogenic specificity at the membrane? Oncogenic KRas, HRas, and NRas (K-Ras, H-Ras, and N-Ras) differentially populate distinct…”
    Get full text
    Journal Article
  3. 3

    Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view by Lu, Shaoyong, Jang, Hyunbum, Gu, Shuo, Zhang, Jian, Nussinov, Ruth

    Published in Chemical Society reviews (21-09-2016)
    “…Ras proteins are small GTPases, cycling between inactive GDP-bound and active GTP-bound states. Through these switches they regulate signaling that controls…”
    Get more information
    Journal Article
  4. 4

    Ras Conformational Ensembles, Allostery, and Signaling by Lu, Shaoyong, Jang, Hyunbum, Muratcioglu, Serena, Gursoy, Attila, Keskin, Ozlem, Nussinov, Ruth, Zhang, Jian

    Published in Chemical reviews (08-06-2016)
    “…Ras proteins are classical members of small GTPases that function as molecular switches by alternating between inactive GDP-bound and active GTP-bound states…”
    Get full text
    Journal Article
  5. 5

    Phosphorylated Calmodulin Promotes PI3K Activation by Binding to the SH2 Domains by Zhang, Mingzhen, Jang, Hyunbum, Gaponenko, Vadim, Nussinov, Ruth

    Published in Biophysical journal (07-11-2017)
    “…How calmodulin (CaM) acts in KRAS-driven cancers is a vastly important question. CaM binds to and stimulates PI3Kα/Akt signaling, promoting cell growth and…”
    Get full text
    Journal Article
  6. 6

    Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers by Nussinov, Ruth, Jang, Hyunbum, Tsai, Chung-Jung, Cheng, Feixiong

    Published in PLoS computational biology (01-03-2019)
    “…At the root of the so-called precision medicine or precision oncology, which is our focus here, is the hypothesis that cancer treatment would be considerably…”
    Get full text
    Journal Article
  7. 7

    Single cell spatial biology over developmental time can decipher pediatric brain pathologies by Nussinov, Ruth, Yavuz, Bengi Ruken, Jang, Hyunbum

    Published in Neurobiology of disease (01-09-2024)
    “…Pediatric low grade brain tumors and neurodevelopmental disorders share proteins, signaling pathways, and networks. They also share germline mutations and an…”
    Get full text
    Journal Article
  8. 8

    Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers by Jang, Hyunbum, Muratcioglu, Serena, Gursoy, Attila, Keskin, Ozlem, Nussinov, Ruth

    Published in Biochemical journal (15-06-2016)
    “…Are the dimer structures of active Ras isoforms similar? This question is significant since Ras can activate its effectors as a monomer; however, as a dimer,…”
    Get more information
    Journal Article
  9. 9

    SOS1 interacts with Grb2 through regions that induce closed nSH3 conformations by Liao, Tsung-Jen, Jang, Hyunbum, Fushman, David, Nussinov, Ruth

    Published in The Journal of chemical physics (28-07-2020)
    “…Grb2 is an adaptor protein connecting the epidermal growth factor receptor and the downstream Son of sevenless 1 (SOS1), a Ras-specific guanine nucleotide…”
    Get more information
    Journal Article
  10. 10

    A New View of Ras Isoforms in Cancers by Nussinov, Ruth, Tsai, Chung-Jung, Chakrabarti, Mayukh, Jang, Hyunbum

    Published in Cancer research (Chicago, Ill.) (01-01-2016)
    “…Does small GTPase K-Ras4A have a single state or two states, one resembling K-Ras4B and the other N-Ras? A recent study of K-Ras4A made the remarkable…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Ras isoform-specific expression, chromatin accessibility, and signaling by Nussinov, Ruth, Zhang, Mingzhen, Maloney, Ryan, Jang, Hyunbum

    Published in Biophysical reviews (01-08-2021)
    “…The anchorage of Ras isoforms in the membrane and their nanocluster formations have been studied extensively, including their detailed interactions, sizes,…”
    Get full text
    Journal Article
  13. 13

    Inhibitors of Ras-SOS Interactions by Lu, Shaoyong, Jang, Hyunbum, Zhang, Jian, Nussinov, Ruth

    Published in ChemMedChem (19-04-2016)
    “…Activating Ras mutations are found in about 30 % of human cancers. Ras activation is regulated by guanine nucleotide exchange factors, such as the son of…”
    Get full text
    Journal Article
  14. 14

    The quaternary assembly of KRas4B with Raf-1 at the membrane by Jang, Hyunbum, Zhang, Mingzhen, Nussinov, Ruth

    “…[Display omitted] Proximally located in the membrane, oncogenic Ras dimers (or nanoclusters) can recruit and promote Raf dimerization and MAPK (Raf/MEK/ERK)…”
    Get full text
    Journal Article
  15. 15

    Does Ras Activate Raf and PI3K Allosterically? by Nussinov, Ruth, Tsai, Chung-Jung, Jang, Hyunbum

    Published in Frontiers in oncology (15-11-2019)
    “…The mechanism through which oncogenic Ras activates its effectors is vastly important to resolve. If allostery is at play, then targeting allosteric pathways…”
    Get full text
    Journal Article
  16. 16

    Tumor-derived RHOA mutants interact with effectors in the GDP-bound state by Lin, Yuan, Ramelot, Theresa A., Senyuz, Simge, Gursoy, Attila, Jang, Hyunbum, Nussinov, Ruth, Keskin, Ozlem, Zheng, Yi

    Published in Nature communications (21-08-2024)
    “…RHOA mutations are found at diverse residues in various cancer types, implying mutation- and cell-specific mechanisms of tumorigenesis. Here, we focus on the…”
    Get full text
    Journal Article
  17. 17

    Antimicrobial Properties of Amyloid Peptides by Kagan, Bruce L, Jang, Hyunbum, Capone, Ricardo, Teran Arce, Fernando, Ramachandran, Srinivasan, Lal, Ratnesh, Nussinov, Ruth

    Published in Molecular pharmaceutics (02-04-2012)
    “…More than two dozen clinical syndromes known as amyloid diseases are characterized by the buildup of extended insoluble fibrillar deposits in tissues. These…”
    Get full text
    Journal Article
  18. 18

    Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome by Jang, Hyunbum, Arce, Fernando Teran, Ramachandran, Srinivasan, Capone, Ricardo, Azimova, Rushana, Kagan, Bruce L, Nussinov, Ruth, Lal, Ratnesh

    “…Full-length amyloid beta peptides (Aβ₁₋₄₀/₄₂) form neuritic amyloid plaques in Alzheimer's disease (AD) patients and are implicated in AD pathology. However,…”
    Get full text
    Journal Article
  19. 19

    The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas by Nussinov, Ruth, Muratcioglu, Serena, Tsai, Chung-Jung, Jang, Hyunbum, Gursoy, Attila, Keskin, Ozlem

    Published in Molecular cancer research (01-09-2015)
    “…KRAS4B is a highly oncogenic splice variant of the KRAS isoform. It is the only isoform associated with initiation of adenocarcinomas. Insight into why and how…”
    Get full text
    Journal Article
  20. 20

    The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane by Jang, Hyunbum, Smith, Iris Nira, Eng, Charis, Nussinov, Ruth

    Published in iScience (21-05-2021)
    “…Tumor suppressor PTEN, the second most highly mutated protein in cancer, dephosphorylates signaling lipid PIP3 produced by PI3Ks. Excess PIP3 promotes cell…”
    Get full text
    Journal Article